Vivimed Labs Ltd.
•₹ 6.244.87%
2026-08-21
PROS
- Working capital cycle has improved - days down from -308 to -512
- Company generates healthy free cash flow
CONS
- Company is loss-making at the operating / net level
- Company has a high debt-to-equity of 18.29x
- Company has a low return on equity of -91.9% over last 3 years
- Company has a low return on capital employed of -21.2%
- Interest coverage is weak at -11.4x - earnings barely cover interest
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.14x)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | VIVIMEDLAB | 5.67 | 0.00 | 47.01 | 0.00 | -147.12 | -2527.20 | 12.00 | -53.14 | -9.07 | -1168.99 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40 | 33 | 30 | 37 | 36 | 25 | 22 | 34 | 23 | 18 | 19 | 12 | 8 | |
| 203 | 33 | 36 | 36 | 65 | 36 | 23 | 34 | 25 | 18 | 20 | 23 | 150 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0 | 0 | 2 | 0 | 7 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 |
| Interest | 8 | 11 | 12 | 13 | -34 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 1 |
| Depreciation | 95 | 4 | 4 | 4 | 5 | 4 | 4 | 6 | 5 | 5 | 5 | 4 | 4 |
| -267 | -15 | -20 | -17 | 7 | -15 | -5 | -7 | -4 | -6 | -7 | -17 | -142 | |
| Tax % | 0.78% | -0.00% | -0.00% | 3.29% | 24.31% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Net Profit | -265 | -15 | -20 | -16 | 6 | -15 | -5 | -7 | -4 | -6 | -7 | -17 | -142 |
| -32 | -2 | -2 | -2 | 1 | -2 | -1 | -1 | -1 | -1 | -1 | -2 | -2 | |
| Equity Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Mar 2023
- 40
- 203
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 8
- Depreciation
- 95
- -267
- Tax %
- 0.78%
- Net Profit
- -265
- -32
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2023
- 33
- 33
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 11
- Depreciation
- 4
- -15
- Tax %
- -0.00%
- Net Profit
- -15
- -2
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 30
- 36
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 12
- Depreciation
- 4
- -20
- Tax %
- -0.00%
- Net Profit
- -20
- -2
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 37
- 36
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 13
- Depreciation
- 4
- -17
- Tax %
- 3.29%
- Net Profit
- -16
- -2
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 36
- 65
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- -34
- Depreciation
- 5
- 7
- Tax %
- 24.31%
- Net Profit
- 6
- 1
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 25
- 36
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 4
- -15
- Tax %
- -0.00%
- Net Profit
- -15
- -2
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 22
- 23
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 4
- -5
- Tax %
- -0.00%
- Net Profit
- -5
- -1
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 34
- 34
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 6
- -7
- Tax %
- -0.00%
- Net Profit
- -7
- -1
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 23
- 25
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 1
- Depreciation
- 5
- -4
- Tax %
- -0.00%
- Net Profit
- -4
- -1
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 18
- 18
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 5
- -6
- Tax %
- -0.00%
- Net Profit
- -6
- -1
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 19
- 20
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 5
- -7
- Tax %
- -0.00%
- Net Profit
- -7
- -1
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 12
- 23
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 4
- -17
- Tax %
- -0.00%
- Net Profit
- -17
- -2
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 8
- 150
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 4
- -142
- Tax %
- -0.00%
- Net Profit
- -142
- -2
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 319 | 570 | 261 | 252 | 277 | 210 | 218 | 177 | 137 | 104 | 56 | |
| 233 | 319 | 183 | 184 | 244 | 182 | 227 | 365 | 170 | 118 | 211 | |
| Operating Profit | 90 | 259 | 80 | 76 | 39 | 34 | -8 | -188 | -24 | -10 | — |
| OPM % | 28 | 45 | 31 | 30 | 14 | 16 | -4 | -106 | -17 | -10 | — |
| Other Income | 3 | 9 | 2 | 9 | 7 | 6 | 1 | 0 | 10 | 4 | 1 |
| Interest | 59 | 59 | 53 | 53 | 43 | 42 | 40 | 36 | 2 | 3 | 4 |
| Depreciation | 19 | 27 | 18 | 18 | 17 | 16 | 17 | 107 | 18 | 19 | 18 |
| 11 | 173 | 9 | 5 | -21 | -24 | -65 | -330 | -44 | -31 | -172 | |
| Tax % | 28 | 27 | -11 | -21 | 8 | 1 | -4 | 1 | 0 | 0 | 0 |
| Net Profit | 8 | 126 | 10 | 6 | -19 | -23 | -68 | -328 | -44 | -31 | -172 |
| EPS | 0 | 0 | 0 | 0 | -2 | -3 | -8 | -38 | -5 | -4 | — |
| Dividend Payout % | 0 | 3 | 33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 1 | 16 | 1 | 1 | -2 | -3 | -8 | -40 | -5 | -4 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 1 | 16 | 1 | 1 | -2 | -3 | -8 | -40 | -5 | -4 | — |
Mar 2016
- 319
- 233
- Operating Profit
- 90
- OPM %
- 28
- Other Income
- 3
- Interest
- 59
- Depreciation
- 19
- 11
- Tax %
- 28
- Net Profit
- 8
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2017
- 570
- 319
- Operating Profit
- 259
- OPM %
- 45
- Other Income
- 9
- Interest
- 59
- Depreciation
- 27
- 173
- Tax %
- 27
- Net Profit
- 126
- EPS
- 0
- Dividend Payout %
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 16
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 16
Mar 2018
- 261
- 183
- Operating Profit
- 80
- OPM %
- 31
- Other Income
- 2
- Interest
- 53
- Depreciation
- 18
- 9
- Tax %
- -11
- Net Profit
- 10
- EPS
- 0
- Dividend Payout %
- 33
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2019
- 252
- 184
- Operating Profit
- 76
- OPM %
- 30
- Other Income
- 9
- Interest
- 53
- Depreciation
- 18
- 5
- Tax %
- -21
- Net Profit
- 6
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2020
- 277
- 244
- Operating Profit
- 39
- OPM %
- 14
- Other Income
- 7
- Interest
- 43
- Depreciation
- 17
- -21
- Tax %
- 8
- Net Profit
- -19
- EPS
- -2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -2
Mar 2021
- 210
- 182
- Operating Profit
- 34
- OPM %
- 16
- Other Income
- 6
- Interest
- 42
- Depreciation
- 16
- -24
- Tax %
- 1
- Net Profit
- -23
- EPS
- -3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -3
Mar 2022
- 218
- 227
- Operating Profit
- -8
- OPM %
- -4
- Other Income
- 1
- Interest
- 40
- Depreciation
- 17
- -65
- Tax %
- -4
- Net Profit
- -68
- EPS
- -8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -8
Mar 2023
- 177
- 365
- Operating Profit
- -188
- OPM %
- -106
- Other Income
- 0
- Interest
- 36
- Depreciation
- 107
- -330
- Tax %
- 1
- Net Profit
- -328
- EPS
- -38
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -40
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -40
Mar 2024
- 137
- 170
- Operating Profit
- -24
- OPM %
- -17
- Other Income
- 10
- Interest
- 2
- Depreciation
- 18
- -44
- Tax %
- 0
- Net Profit
- -44
- EPS
- -5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -5
Mar 2025
- 104
- 118
- Operating Profit
- -10
- OPM %
- -10
- Other Income
- 4
- Interest
- 3
- Depreciation
- 19
- -31
- Tax %
- 0
- Net Profit
- -31
- EPS
- -4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -4
TTM
- 56
- 211
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 4
- Depreciation
- 18
- -172
- Tax %
- 0
- Net Profit
- -172
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- -13%
- 5 Years:
- -18%
- 3 Years:
- -22%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- -23%
- 5 Years:
- -22%
- 3 Years:
- -15%
- 1 Year:
- -39%
RETURN ON EQUITY
- 10 Years:
- -27%
- 5 Years:
- -59%
- 3 Years:
- -92%
- Last Year:
- -88%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 16 | 16 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| 353 | 545 | 551 | 556 | 537 | 508 | 441 | 117 | 73 | 42 | |
| 292 | 306 | 259 | 214 | 188 | 194 | 216 | 223 | 312 | 312 | |
| Trade Payables | 24 | 45 | 23 | 35 | 31 | 33 | 37 | 56 | 39 | 34 |
| 679 | 449 | 406 | 333 | 295 | 344 | 361 | 383 | 241 | 235 | |
| Total Liabilities | 1,365 | 1,361 | 1,255 | 1,155 | 1,067 | 1,095 | 1,072 | 796 | 682 | 639 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 387 | 433 | 405 | 381 | 356 | 417 | 429 | 343 | 326 | 315 | |
| Capital Work in Progress | 41 | 59 | 43 | 64 | 70 | 58 | 40 | 21 | 21 | 17 |
| 230 | 88 | 152 | 88 | 88 | 161 | 161 | 161 | 59 | 59 | |
| 268 | 286 | 293 | 282 | 263 | 254 | 239 | 78 | 63 | 56 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60 | 46 | |
| Cash & Bank | 7 | 16 | 9 | 25 | 11 | 6 | 7 | 3 | 1 | 0 |
| 432 | 480 | 354 | 315 | 279 | 199 | 196 | 190 | 153 | 145 | |
| Total Assets | 1,365 | 1,361 | 1,255 | 1,155 | 1,067 | 1,095 | 1,072 | 796 | 682 | 639 |
| Total Debt | 599 | 571 | 446 | 348 | 304 | 323 | 357 | 377 | 375 | 375 |
| Net Working Capital | 262 | 278 | 256 | 284 | 252 | 129 | 76 | -141 | -115 | -145 |
| Contingent Liabilities | 397 | 237 | 161 | 56 | 12 | 221 | 216 | 123 | 116 | 183 |
| Book Value per Share | 227.50 | 64.53 | 64.15 | 64.78 | 62.22 | 58.67 | 50.57 | 11.50 | 6.20 | 2.47 |
| Face Value | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Total Debt | 599 | 571 | 446 | 348 | 304 | 323 | 357 | 377 | 375 | 375 |
| Net Working Capital | 262 | 278 | 256 | 284 | 252 | 129 | 76 | -141 | -115 | -145 |
| Contingent Liabilities | 397 | 237 | 161 | 56 | 12 | 221 | 216 | 123 | 116 | 183 |
| Book Value per Share | 227.50 | 64.53 | 64.15 | 64.78 | 62.22 | 58.67 | 50.57 | 11.50 | 6.20 | 2.47 |
| Face Value | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Mar 2016
- Equity Capital
- 16
- 353
- 292
- Trade Payables
- 24
- 679
- Total Liabilities
- 1,365
- 387
- Capital Work in Progress
- 41
- 230
- 268
- 0
- Cash & Bank
- 7
- 432
- Total Assets
- 1,365
- Total Debt
- 599
- Net Working Capital
- 262
- Contingent Liabilities
- 397
- Book Value per Share
- 227.50
- Face Value
- 10.00
- Total Debt
- 599
- Net Working Capital
- 262
- Contingent Liabilities
- 397
- Book Value per Share
- 227.50
- Face Value
- 10.00
Mar 2017
- Equity Capital
- 16
- 545
- 306
- Trade Payables
- 45
- 449
- Total Liabilities
- 1,361
- 433
- Capital Work in Progress
- 59
- 88
- 286
- 0
- Cash & Bank
- 16
- 480
- Total Assets
- 1,361
- Total Debt
- 571
- Net Working Capital
- 278
- Contingent Liabilities
- 237
- Book Value per Share
- 64.53
- Face Value
- 2.00
- Total Debt
- 571
- Net Working Capital
- 278
- Contingent Liabilities
- 237
- Book Value per Share
- 64.53
- Face Value
- 2.00
Mar 2018
- Equity Capital
- 17
- 551
- 259
- Trade Payables
- 23
- 406
- Total Liabilities
- 1,255
- 405
- Capital Work in Progress
- 43
- 152
- 293
- 0
- Cash & Bank
- 9
- 354
- Total Assets
- 1,255
- Total Debt
- 446
- Net Working Capital
- 256
- Contingent Liabilities
- 161
- Book Value per Share
- 64.15
- Face Value
- 2.00
- Total Debt
- 446
- Net Working Capital
- 256
- Contingent Liabilities
- 161
- Book Value per Share
- 64.15
- Face Value
- 2.00
Mar 2019
- Equity Capital
- 17
- 556
- 214
- Trade Payables
- 35
- 333
- Total Liabilities
- 1,155
- 381
- Capital Work in Progress
- 64
- 88
- 282
- 0
- Cash & Bank
- 25
- 315
- Total Assets
- 1,155
- Total Debt
- 348
- Net Working Capital
- 284
- Contingent Liabilities
- 56
- Book Value per Share
- 64.78
- Face Value
- 2.00
- Total Debt
- 348
- Net Working Capital
- 284
- Contingent Liabilities
- 56
- Book Value per Share
- 64.78
- Face Value
- 2.00
Mar 2020
- Equity Capital
- 17
- 537
- 188
- Trade Payables
- 31
- 295
- Total Liabilities
- 1,067
- 356
- Capital Work in Progress
- 70
- 88
- 263
- 0
- Cash & Bank
- 11
- 279
- Total Assets
- 1,067
- Total Debt
- 304
- Net Working Capital
- 252
- Contingent Liabilities
- 12
- Book Value per Share
- 62.22
- Face Value
- 2.00
- Total Debt
- 304
- Net Working Capital
- 252
- Contingent Liabilities
- 12
- Book Value per Share
- 62.22
- Face Value
- 2.00
Mar 2021
- Equity Capital
- 17
- 508
- 194
- Trade Payables
- 33
- 344
- Total Liabilities
- 1,095
- 417
- Capital Work in Progress
- 58
- 161
- 254
- 0
- Cash & Bank
- 6
- 199
- Total Assets
- 1,095
- Total Debt
- 323
- Net Working Capital
- 129
- Contingent Liabilities
- 221
- Book Value per Share
- 58.67
- Face Value
- 2.00
- Total Debt
- 323
- Net Working Capital
- 129
- Contingent Liabilities
- 221
- Book Value per Share
- 58.67
- Face Value
- 2.00
Mar 2022
- Equity Capital
- 17
- 441
- 216
- Trade Payables
- 37
- 361
- Total Liabilities
- 1,072
- 429
- Capital Work in Progress
- 40
- 161
- 239
- 0
- Cash & Bank
- 7
- 196
- Total Assets
- 1,072
- Total Debt
- 357
- Net Working Capital
- 76
- Contingent Liabilities
- 216
- Book Value per Share
- 50.57
- Face Value
- 2.00
- Total Debt
- 357
- Net Working Capital
- 76
- Contingent Liabilities
- 216
- Book Value per Share
- 50.57
- Face Value
- 2.00
Mar 2023
- Equity Capital
- 17
- 117
- 223
- Trade Payables
- 56
- 383
- Total Liabilities
- 796
- 343
- Capital Work in Progress
- 21
- 161
- 78
- 0
- Cash & Bank
- 3
- 190
- Total Assets
- 796
- Total Debt
- 377
- Net Working Capital
- -141
- Contingent Liabilities
- 123
- Book Value per Share
- 11.50
- Face Value
- 2.00
- Total Debt
- 377
- Net Working Capital
- -141
- Contingent Liabilities
- 123
- Book Value per Share
- 11.50
- Face Value
- 2.00
Mar 2024
- Equity Capital
- 17
- 73
- 312
- Trade Payables
- 39
- 241
- Total Liabilities
- 682
- 326
- Capital Work in Progress
- 21
- 59
- 63
- 60
- Cash & Bank
- 1
- 153
- Total Assets
- 682
- Total Debt
- 375
- Net Working Capital
- -115
- Contingent Liabilities
- 116
- Book Value per Share
- 6.20
- Face Value
- 2.00
- Total Debt
- 375
- Net Working Capital
- -115
- Contingent Liabilities
- 116
- Book Value per Share
- 6.20
- Face Value
- 2.00
Mar 2025
- Equity Capital
- 17
- 42
- 312
- Trade Payables
- 34
- 235
- Total Liabilities
- 639
- 315
- Capital Work in Progress
- 17
- 59
- 56
- 46
- Cash & Bank
- 0
- 145
- Total Assets
- 639
- Total Debt
- 375
- Net Working Capital
- -145
- Contingent Liabilities
- 183
- Book Value per Share
- 2.47
- Face Value
- 2.00
- Total Debt
- 375
- Net Working Capital
- -145
- Contingent Liabilities
- 183
- Book Value per Share
- 2.47
- Face Value
- 2.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| -54 | 28 | 207 | 82 | 75 | 180 | 25 | 33 | -97 | 6 | |
| Cash from Investing | -11 | 30 | -38 | 56 | 3 | -138 | -11 | -2 | 100 | -4 |
| Cash from Financing | 59 | -50 | -175 | -123 | -91 | -46 | -13 | -35 | -6 | -3 |
| -7 | 8 | -6 | 15 | -13 | -5 | 1 | -3 | -2 | -1 | |
| Free Cash Flow | -61 | 3 | 207 | 67 | 75 | 115 | 14 | 33 | -98 | 2 |
| OCF / Net Profit | -6.67 | 0.22 | 20.93 | 13.26 | -3.91 | -7.71 | -0.37 | -0.10 | 2.17 | -0.18 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 290 | 466 | 477 | 303 | 138 | 65 |
| OCF / Net Profit | -6.67 | 0.22 | 20.93 | 13.26 | -3.91 | -7.71 | -0.37 | -0.10 | 2.17 | -0.18 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 290 | 466 | 477 | 303 | 138 | 65 |
Mar 2016
- -54
- Cash from Investing
- -11
- Cash from Financing
- 59
- -7
- Free Cash Flow
- -61
- OCF / Net Profit
- -6.67
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -6.67
- Cumulative 5-Year FCF
- 0
Mar 2017
- 28
- Cash from Investing
- 30
- Cash from Financing
- -50
- 8
- Free Cash Flow
- 3
- OCF / Net Profit
- 0.22
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.22
- Cumulative 5-Year FCF
- 0
Mar 2018
- 207
- Cash from Investing
- -38
- Cash from Financing
- -175
- -6
- Free Cash Flow
- 207
- OCF / Net Profit
- 20.93
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 20.93
- Cumulative 5-Year FCF
- 0
Mar 2019
- 82
- Cash from Investing
- 56
- Cash from Financing
- -123
- 15
- Free Cash Flow
- 67
- OCF / Net Profit
- 13.26
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 13.26
- Cumulative 5-Year FCF
- 0
Mar 2020
- 75
- Cash from Investing
- 3
- Cash from Financing
- -91
- -13
- Free Cash Flow
- 75
- OCF / Net Profit
- -3.91
- Cumulative 5-Year FCF
- 290
- OCF / Net Profit
- -3.91
- Cumulative 5-Year FCF
- 290
Mar 2021
- 180
- Cash from Investing
- -138
- Cash from Financing
- -46
- -5
- Free Cash Flow
- 115
- OCF / Net Profit
- -7.71
- Cumulative 5-Year FCF
- 466
- OCF / Net Profit
- -7.71
- Cumulative 5-Year FCF
- 466
Mar 2022
- 25
- Cash from Investing
- -11
- Cash from Financing
- -13
- 1
- Free Cash Flow
- 14
- OCF / Net Profit
- -0.37
- Cumulative 5-Year FCF
- 477
- OCF / Net Profit
- -0.37
- Cumulative 5-Year FCF
- 477
Mar 2023
- 33
- Cash from Investing
- -2
- Cash from Financing
- -35
- -3
- Free Cash Flow
- 33
- OCF / Net Profit
- -0.10
- Cumulative 5-Year FCF
- 303
- OCF / Net Profit
- -0.10
- Cumulative 5-Year FCF
- 303
Mar 2024
- -97
- Cash from Investing
- 100
- Cash from Financing
- -6
- -2
- Free Cash Flow
- -98
- OCF / Net Profit
- 2.17
- Cumulative 5-Year FCF
- 138
- OCF / Net Profit
- 2.17
- Cumulative 5-Year FCF
- 138
Mar 2025
- 6
- Cash from Investing
- -4
- Cash from Financing
- -3
- -1
- Free Cash Flow
- 2
- OCF / Net Profit
- -0.18
- Cumulative 5-Year FCF
- 65
- OCF / Net Profit
- -0.18
- Cumulative 5-Year FCF
- 65
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 5.02 | 15.59 | 1.20 | 0.75 | -2.31 | -2.81 | -8.17 | -39.56 | -5.35 | -3.80 |
| Book Value (₹) | 227.50 | 64.53 | 64.15 | 64.78 | 62.22 | 58.67 | 50.57 | 11.50 | 6.20 | 2.47 |
| Dividend per Share (₹) | 0.00 | 0.40 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 3.32 | 18.91 | 3.39 | 2.96 | -0.31 | -0.90 | -6.07 | -26.67 | -3.13 | -1.55 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 28.06% | 45.49% | 30.71% | 30.19% | 14.20% | 16.22% | -3.56% | -106.13% | -24.22% | -14.01% |
| Net Margin % | 2.54% | 22.17% | 3.77% | 2.46% | -6.93% | -11.08% | -31.03% | -185.50% | -32.44% | -30.40% |
| ROE % | 2.19% | 28.34% | 1.88% | 1.16% | -3.65% | -4.64% | -14.96% | -127.49% | -60.50% | -87.61% |
| ROCE % | 6.95% | 22.55% | 6.01% | 6.22% | 2.67% | 2.24% | -3.18% | -47.20% | -9.34% | -7.04% |
| 0.61% | 9.27% | 0.75% | 0.51% | -1.73% | -2.15% | -6.25% | -35.12% | -6.01% | -4.77% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 262 | 146 | 274 | 195 | 126 | 145 | 117 | 117 | 147 | 186 |
| Inventory Days | 280 | 177 | 404 | 417 | 360 | 449 | 412 | 328 | 188 | 210 |
| Payable Days | 97 | 71 | 145 | 133 | 80 | 120 | 89 | 64 | 258 | 227 |
| 445 | 253 | 533 | 479 | 406 | 474 | 439 | 381 | 77 | 169 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 1.62x | 1.09x | 0.84x | 0.65x | 0.59x | 0.66x | 0.85x | 3.95x | 7.30x | 18.29x |
| Interest Coverage (x) | 1.19x | 3.94x | 1.17x | 1.10x | 0.52x | 0.44x | -0.64x | -8.29x | -17.39x | -11.41x |
| 1.59x | 1.55x | 1.64x | 1.84x | 1.84x | 1.39x | 1.21x | 0.66x | 0.71x | 0.63x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -25.75% | 78.41% | -54.13% | -3.66% | 9.85% | -24.06% | 3.96% | -19.02% | -22.64% | -24.26% |
| Operating Profit Growth % | -19.61% | 189.24% | -69.04% | -5.29% | -48.35% | -13.27% | -122.83% | -2313.12% | 87.45% | 56.16% |
| Net Profit Growth % | -57.07% | 1454.62% | -92.19% | -37.31% | -409.89% | -21.43% | -191.04% | -384.13% | 86.47% | 29.03% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 86.47% | 29.03% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -16.59x | -37.87x |
Mar 2016
- EPS (₹)
- 5.02
- Book Value (₹)
- 227.50
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.32
- Operating Margin %
- 28.06%
- Net Margin %
- 2.54%
- ROE %
- 2.19%
- ROCE %
- 6.95%
- 0.61%
- Debtor Days
- 262
- Inventory Days
- 280
- Payable Days
- 97
- 445
- Debt to Equity (x)
- 1.62x
- Interest Coverage (x)
- 1.19x
- 1.59x
- Revenue Growth %
- -25.75%
- Operating Profit Growth %
- -19.61%
- Net Profit Growth %
- -57.07%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- 15.59
- Book Value (₹)
- 64.53
- Dividend per Share (₹)
- 0.40
- Cash EPS (₹)
- 18.91
- Operating Margin %
- 45.49%
- Net Margin %
- 22.17%
- ROE %
- 28.34%
- ROCE %
- 22.55%
- 9.27%
- Debtor Days
- 146
- Inventory Days
- 177
- Payable Days
- 71
- 253
- Debt to Equity (x)
- 1.09x
- Interest Coverage (x)
- 3.94x
- 1.55x
- Revenue Growth %
- 78.41%
- Operating Profit Growth %
- 189.24%
- Net Profit Growth %
- 1454.62%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 1.20
- Book Value (₹)
- 64.15
- Dividend per Share (₹)
- 0.40
- Cash EPS (₹)
- 3.39
- Operating Margin %
- 30.71%
- Net Margin %
- 3.77%
- ROE %
- 1.88%
- ROCE %
- 6.01%
- 0.75%
- Debtor Days
- 274
- Inventory Days
- 404
- Payable Days
- 145
- 533
- Debt to Equity (x)
- 0.84x
- Interest Coverage (x)
- 1.17x
- 1.64x
- Revenue Growth %
- -54.13%
- Operating Profit Growth %
- -69.04%
- Net Profit Growth %
- -92.19%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 0.75
- Book Value (₹)
- 64.78
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.96
- Operating Margin %
- 30.19%
- Net Margin %
- 2.46%
- ROE %
- 1.16%
- ROCE %
- 6.22%
- 0.51%
- Debtor Days
- 195
- Inventory Days
- 417
- Payable Days
- 133
- 479
- Debt to Equity (x)
- 0.65x
- Interest Coverage (x)
- 1.10x
- 1.84x
- Revenue Growth %
- -3.66%
- Operating Profit Growth %
- -5.29%
- Net Profit Growth %
- -37.31%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- -2.31
- Book Value (₹)
- 62.22
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -0.31
- Operating Margin %
- 14.20%
- Net Margin %
- -6.93%
- ROE %
- -3.65%
- ROCE %
- 2.67%
- -1.73%
- Debtor Days
- 126
- Inventory Days
- 360
- Payable Days
- 80
- 406
- Debt to Equity (x)
- 0.59x
- Interest Coverage (x)
- 0.52x
- 1.84x
- Revenue Growth %
- 9.85%
- Operating Profit Growth %
- -48.35%
- Net Profit Growth %
- -409.89%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- -2.81
- Book Value (₹)
- 58.67
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -0.90
- Operating Margin %
- 16.22%
- Net Margin %
- -11.08%
- ROE %
- -4.64%
- ROCE %
- 2.24%
- -2.15%
- Debtor Days
- 145
- Inventory Days
- 449
- Payable Days
- 120
- 474
- Debt to Equity (x)
- 0.66x
- Interest Coverage (x)
- 0.44x
- 1.39x
- Revenue Growth %
- -24.06%
- Operating Profit Growth %
- -13.27%
- Net Profit Growth %
- -21.43%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- -8.17
- Book Value (₹)
- 50.57
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -6.07
- Operating Margin %
- -3.56%
- Net Margin %
- -31.03%
- ROE %
- -14.96%
- ROCE %
- -3.18%
- -6.25%
- Debtor Days
- 117
- Inventory Days
- 412
- Payable Days
- 89
- 439
- Debt to Equity (x)
- 0.85x
- Interest Coverage (x)
- -0.64x
- 1.21x
- Revenue Growth %
- 3.96%
- Operating Profit Growth %
- -122.83%
- Net Profit Growth %
- -191.04%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- -39.56
- Book Value (₹)
- 11.50
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -26.67
- Operating Margin %
- -106.13%
- Net Margin %
- -185.50%
- ROE %
- -127.49%
- ROCE %
- -47.20%
- -35.12%
- Debtor Days
- 117
- Inventory Days
- 328
- Payable Days
- 64
- 381
- Debt to Equity (x)
- 3.95x
- Interest Coverage (x)
- -8.29x
- 0.66x
- Revenue Growth %
- -19.02%
- Operating Profit Growth %
- -2313.12%
- Net Profit Growth %
- -384.13%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -5.35
- Book Value (₹)
- 6.20
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -3.13
- Operating Margin %
- -24.22%
- Net Margin %
- -32.44%
- ROE %
- -60.50%
- ROCE %
- -9.34%
- -6.01%
- Debtor Days
- 147
- Inventory Days
- 188
- Payable Days
- 258
- 77
- Debt to Equity (x)
- 7.30x
- Interest Coverage (x)
- -17.39x
- 0.71x
- Revenue Growth %
- -22.64%
- Operating Profit Growth %
- 87.45%
- Net Profit Growth %
- 86.47%
- 86.47%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- -16.59x
Mar 2025
- EPS (₹)
- -3.80
- Book Value (₹)
- 2.47
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -1.55
- Operating Margin %
- -14.01%
- Net Margin %
- -30.40%
- ROE %
- -87.61%
- ROCE %
- -7.04%
- -4.77%
- Debtor Days
- 186
- Inventory Days
- 210
- Payable Days
- 227
- 169
- Debt to Equity (x)
- 18.29x
- Interest Coverage (x)
- -11.41x
- 0.63x
- Revenue Growth %
- -24.26%
- Operating Profit Growth %
- 56.16%
- Net Profit Growth %
- 29.03%
- 29.03%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- -37.87x
Documents
Announcements
- Corporate Insolvency Resolution Process
2026-08-17 - Vivimed Labs Limited has informed the Exchange about Corporate Insolvency Resolution Process
- Clarification - Financial Results
2026-07-31 - The Exchange has sought clarification from Vivimed Labs Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
Annual Reports
Credit Ratings
Nothing filed yet.